inositol has been researched along with Diabetes, Gestational in 69 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hence, it can be concluded that approximately one out of every four overweight pregnant women receiving myo-inositol benefitted from its daily intake." | 9.69 | The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial. ( Basirat, Z; Delavar, MA; Esmaeilzadeh, S; Ghadimi, R; Mashayekh-Amiri, S, 2023) |
| " Inclusion criteria were randomized controlled trials (RCTs) that enrolled overweight and obese pregnant women and used myo-inositol supplementation." | 9.41 | The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. ( Corpuz, H; Factor, PA, 2023) |
| "This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women." | 9.41 | Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. ( Caruso, S; Cianci, A; Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Vitale, SG, 2021) |
| "To verify whether myo-inositol plus α-lactalbumin may reduce insulin resistance and excessive fetal growth in women with gestational diabetes mellitus." | 9.41 | Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. ( Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Gullo, G; Loddo, S, 2021) |
| "This trial will provide evidence for the effectiveness of myo-inositol supplementation during pregnancy in reducing the incidence of gestational diabetes mellitus." | 9.34 | Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial. ( Anastasiou, E; Antsaklis, P; Asimakopoulos, G; Daskalakis, G; Kallergi, A; Loutradis, D; Pergialiotis, V; Sindos, M; Theodora, M; Vogiatzi, E, 2020) |
| "To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women." | 9.22 | Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. ( Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Neri, I; Petrella, E; Pintaudi, B; Santamaria, A, 2016) |
| "Myo-inositol supplementation in pregnancy reduced the incidence of GDM in women at high risk of this disorder." | 9.17 | Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. ( Celentano, C; D'Angelo, M; Liberati, M; Matarrelli, B; Mattei, PA; Pavone, G; Vitacolonna, E, 2013) |
| "To test the hypothesis that myoinositol supplementation will improve insulin sensitivity as measured by markers of insulin resistance such as homeostasis model assessment of insulin resistance and adiponectin in women with gestational diabetes." | 9.15 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Vieste, G; Giordano, D; Pintaudi, B; Santamaria, A, 2011) |
| "The aim of this review is to present the current data about the role of inositols in the management of polycystic ovary syndrome (PCOS) women and in the prevention and treatment of gestational diabetes mellitus (GDM)." | 8.98 | The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. ( Gateva, A; Kamenov, Z; Unfer, V, 2018) |
| "Evidence from four trials of antenatal dietary supplementation with myo-inositol during pregnancy shows a potential benefit for reducing the incidence of gestational diabetes." | 8.91 | Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. ( Alsweiler, J; Brown, J; Crawford, TJ; Crowther, CA, 2015) |
| "Our study aims to demonstrate that the use in the preconceptional period until the 24th week of pregnancy of inositol and folic acid, first of all, preserves the product of conception from neural tube defects (NTDs) and then, thanks to inositol supplementation, it possibly counteracts and prevents the onset of maternal gestational diabetes (GDM)." | 7.85 | Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results. ( Allegretti, A; Benedetto, M; Capalbo, A; D'Apice, MR; Dell'Edera, D; Epifania, AA; Lupo, MG; Sarlo, F; Simone, F, 2017) |
| "In recent years, interest has been focused to the study of the two major inositol stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as second messengers of insulin, in several insulin-dependent processes, such as metabolic syndrome and polycystic ovary syndrome." | 7.81 | Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. ( Benvenga, S; Bevilacqua, A; Bizzarri, M; Carlomagno, G; Cavalli, P; Chiu, TT; D'Anna, R; Devroey, P; Di Renzo, GC; Facchinetti, F; Gerli, S; Hod, M; Kamenov, ZA; Lanzone, A; Oliva, MM; Soulage, C, 2015) |
| "Pregnancy is similarly characterized by substantial and complex changes in glycemic and lipidomic regulation as part of maternal adaptation and is also associated with physiological alterations in inositol processing." | 6.82 | A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. ( Chan, SY; Sharma, N; Watkins, OC; Yong, HEJ, 2022) |
| "Pregnancy is characterized by a physiologic increase in insulin resistance, which, associated with increased oxidative stress and inflammations, could induce alterations of glucose metabolism and diabetes." | 6.61 | Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. ( Baldassarre, MPA; Bucci, I; Carlucci, MA; Consoli, A; Formoso, G; Ginestra, F, 2019) |
| " Hence, it can be concluded that approximately one out of every four overweight pregnant women receiving myo-inositol benefitted from its daily intake." | 5.69 | The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial. ( Basirat, Z; Delavar, MA; Esmaeilzadeh, S; Ghadimi, R; Mashayekh-Amiri, S, 2023) |
| "The research confirmed that myo-inositol supplementation can improve global sleep quality, subjective sleep quality, and sleep duration during pregnancy." | 5.51 | The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study. ( Bakouei, F; Delavar, MA; Esmaeilzadeh, S; Faramarzi, M; Mashayekh-Amiri, S, 2022) |
| "The effects of gestational diabetes mellitus (GDM) were determined on urinary excretion of putative components of insulin signaling." | 5.43 | Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus. ( Koos, B; Markovic, D; Murphy, A; Ostlund, R; Shamshirsaz, A, 2016) |
| "Evidence from seven studies shows that antenatal dietary supplementation with myo-inositol during pregnancy may reduce the incidence of gestational diabetes, hypertensive disorders of pregnancy and preterm birth." | 5.41 | Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes. ( Alsweiler, J; Crawford, TJ; Crowther, CA; Lin, L; Motuhifonua, SK, 2023) |
| " Inclusion criteria were randomized controlled trials (RCTs) that enrolled overweight and obese pregnant women and used myo-inositol supplementation." | 5.41 | The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. ( Corpuz, H; Factor, PA, 2023) |
| "This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women." | 5.41 | Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. ( Caruso, S; Cianci, A; Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Vitale, SG, 2021) |
| " Except one woman in the myoinositol group, all women provided glycaemia data throughout their pregnancy." | 5.41 | Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial. ( Balani, S; Bhatla, N; Kachhawa, G; Kulshrestha, V; Kumari, R; Sharma, JB; Vanamail, P, 2021) |
| "To verify whether myo-inositol plus α-lactalbumin may reduce insulin resistance and excessive fetal growth in women with gestational diabetes mellitus." | 5.41 | Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. ( Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Gullo, G; Loddo, S, 2021) |
| "This trial will provide evidence for the effectiveness of myo-inositol supplementation during pregnancy in reducing the incidence of gestational diabetes mellitus." | 5.34 | Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial. ( Anastasiou, E; Antsaklis, P; Asimakopoulos, G; Daskalakis, G; Kallergi, A; Loutradis, D; Pergialiotis, V; Sindos, M; Theodora, M; Vogiatzi, E, 2020) |
| "Our study provides interesting but preliminary results about the potential role of inositol stereoisomers supplementation in the treatment of GDM on insulin resistance levels and several maternal-fetal outcomes." | 5.27 | Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. ( Celentano, C; Di Nicola, M; Di Vieste, G; Franzago, M; Fraticelli, F; Liberati, M; Pintaudi, B; Vitacolonna, E; Zecca, IA, 2018) |
| "Commencing an inositol combination in early pregnancy did not prevent GDM in women with a family history of diabetes." | 5.24 | The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. ( Daly, N; Daly, S; Farren, M; Kinsley, B; McKeating, A; Turner, MJ, 2017) |
| "This study was aimed at assessing the efficacy and safety of inositol nutritional supplementation during pregnancy for the prevention of GDM." | 5.22 | Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Wei, J; Yan, J; Yang, H, 2022) |
| "To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women." | 5.22 | Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. ( Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Neri, I; Petrella, E; Pintaudi, B; Santamaria, A, 2016) |
| "There is growing interest in the potential role of different stereoisomers of inositol or their combination as well as probiotics supplementation in healthy glucose metabolism during pregnancy and in promoting offspring health." | 5.22 | Inositols, Probiotics, and Gestational Diabetes: Clinical and Epigenetic Aspects. ( Franzago, M; Masulli, M; Palmisano, L; Stuppia, L; Vitacolonna, E, 2022) |
| "In an open-label, randomized trial, myo-inositol (2 g plus 200 micrograms folic acid twice a day) or placebo (200 micrograms folic acid twice a day) was administered from the first trimester to delivery in pregnant obese women (prepregnancy body mass index 30 or greater." | 5.20 | Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial. ( Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Interdonato, ML; Neri, I; Petrella, E; Pintaudi, B; Santamaria, A; Scilipoti, A, 2015) |
| "Myo-inositol supplementation in pregnancy reduced the incidence of GDM in women at high risk of this disorder." | 5.17 | Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. ( Celentano, C; D'Angelo, M; Liberati, M; Matarrelli, B; Mattei, PA; Pavone, G; Vitacolonna, E, 2013) |
| "To test the hypothesis that myoinositol supplementation will improve insulin sensitivity as measured by markers of insulin resistance such as homeostasis model assessment of insulin resistance and adiponectin in women with gestational diabetes." | 5.15 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Vieste, G; Giordano, D; Pintaudi, B; Santamaria, A, 2011) |
| "The aim of this review is to present the current data about the role of inositols in the management of polycystic ovary syndrome (PCOS) women and in the prevention and treatment of gestational diabetes mellitus (GDM)." | 4.98 | The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. ( Gateva, A; Kamenov, Z; Unfer, V, 2018) |
| "Evidence from four trials of antenatal dietary supplementation with myo-inositol during pregnancy shows a potential benefit for reducing the incidence of gestational diabetes." | 4.91 | Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. ( Alsweiler, J; Brown, J; Crawford, TJ; Crowther, CA, 2015) |
| "Maternal hyperglycemia is associated with disrupted transplacental arachidonic acid (AA) supply and eicosanoid synthesis, which contribute to adverse pregnancy outcomes." | 4.12 | Myo-Inositol Moderates Glucose-Induced Effects on Human Placental ( Bendt, AK; Cazenave-Gassiot, A; Chan, SY; Cracknell-Hazra, VKB; Godfrey, KM; Lewis, RM; Patmanathan, SN; Pillai, RA; Selvam, P; Sharma, N; Watkins, OC; Wenk, MR; Yong, HEJ, 2022) |
| "A secondary analysis of databases from 3 randomized, controlled trials (595 women enrolled) in which women who were at risk for gestational diabetes mellitus (a parent with type 2 diabetes mellitus, obese, or overweight) were supplemented with myo-inositol (4 g/d) throughout pregnancy." | 3.88 | Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. ( Alibrandi, A; Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Pintaudi, B; Santamaria, A, 2018) |
| "Our study aims to demonstrate that the use in the preconceptional period until the 24th week of pregnancy of inositol and folic acid, first of all, preserves the product of conception from neural tube defects (NTDs) and then, thanks to inositol supplementation, it possibly counteracts and prevents the onset of maternal gestational diabetes (GDM)." | 3.85 | Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results. ( Allegretti, A; Benedetto, M; Capalbo, A; D'Apice, MR; Dell'Edera, D; Epifania, AA; Lupo, MG; Sarlo, F; Simone, F, 2017) |
| "In recent years, interest has been focused to the study of the two major inositol stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as second messengers of insulin, in several insulin-dependent processes, such as metabolic syndrome and polycystic ovary syndrome." | 3.81 | Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. ( Benvenga, S; Bevilacqua, A; Bizzarri, M; Carlomagno, G; Cavalli, P; Chiu, TT; D'Anna, R; Devroey, P; Di Renzo, GC; Facchinetti, F; Gerli, S; Hod, M; Kamenov, ZA; Lanzone, A; Oliva, MM; Soulage, C, 2015) |
| "To evaluate retrospectively the prevalence of gestational diabetes (GD) in pregnancies obtained with myo-inositol administration in women with polycystic ovary syndrome." | 3.78 | Myo-inositol may prevent gestational diabetes in PCOS women. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Benedetto, V; Interdonato, ML; Raffone, E; Rizzo, P, 2012) |
| "Although gestational diabetes mellitus (GDM) has several short- and long-term adverse effects on the mother and the offspring, no medicine is generally prescribed to prevent GDM." | 3.01 | Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Ács, N; Greff, D; Hegyi, P; Horváth, EM; Nyirády, P; Park, S; Szinte, J; Váncsa, S; Váradi, A; Várbíró, S, 2023) |
| "Pregnancy is similarly characterized by substantial and complex changes in glycemic and lipidomic regulation as part of maternal adaptation and is also associated with physiological alterations in inositol processing." | 2.82 | A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. ( Chan, SY; Sharma, N; Watkins, OC; Yong, HEJ, 2022) |
| "The prevalence of gestational diabetes mellitus (GDM) is increasing, with approximately 15% of pregnant women affected worldwide, varying by country, ethnicity and diagnostic thresholds." | 2.66 | Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews. ( Alsweiler, J; Brown, S; Crowther, CA; Griffith, RJ; Middleton, P; Moore, AE; Shepherd, E, 2020) |
| "Pregnancy is characterized by a physiologic increase in insulin resistance, which, associated with increased oxidative stress and inflammations, could induce alterations of glucose metabolism and diabetes." | 2.61 | Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. ( Baldassarre, MPA; Bucci, I; Carlucci, MA; Consoli, A; Formoso, G; Ginestra, F, 2019) |
| "Myo-inositol is related to lower incidence of GDM, as well as fasting, 1h, and 2h OGTT value, in pregnant women with high risk of this condition." | 2.58 | Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. ( Guo, S; Guo, X; Li, Z; Miao, Z; Zhang, H, 2018) |
| "Inositol has been proposed as a food supplement that might reduce gestational diabetes incidence in high-risk pregnant women." | 2.53 | Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus. ( Celentano, C; Liberati, M; Matarrelli, B; Mattei, PA; Pavone, G; Vitacolonna, E, 2016) |
| "The rise in gestational diabetes (GDM), defined as first onset or diagnosis of diabetes in pregnancy, is a global problem." | 2.52 | Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a meta-analysis of randomised studies. ( Chamillard, M; Hitman, GA; Khan, KS; Rogozińska, E; Thangaratinam, S, 2015) |
| "Myo-inositol supplementation prevents gestational diabetes (GDM) in women at risk and reduces insulin resistance in women with GDM." | 1.48 | Effects of myo-inositol on glucose variability in women with gestational diabetes. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Vieste, G; Giunta, L; Lucisano, G; Pintaudi, B, 2018) |
| "The effects of gestational diabetes mellitus (GDM) were determined on urinary excretion of putative components of insulin signaling." | 1.43 | Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus. ( Koos, B; Markovic, D; Murphy, A; Ostlund, R; Shamshirsaz, A, 2016) |
| "Myoinositol is a promising supplement that may represent the first GDM-risk modifier that could be implemented on a population-level." | 1.43 | The Potential Role for Myoinositol in the Prevention of Gestational Diabetes Mellitus. ( Froehlich, RJ; Werner, EF, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 38 (55.07) | 24.3611 |
| 2020's | 31 (44.93) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, N | 4 |
| Watkins, OC | 4 |
| Chu, AHY | 3 |
| Cutfield, W | 1 |
| Godfrey, KM | 4 |
| Yong, HEJ | 3 |
| Chan, SY | 6 |
| Dinicola, S | 1 |
| Unfer, V | 5 |
| Facchinetti, F | 7 |
| Soulage, CO | 2 |
| Greene, ND | 1 |
| Bizzarri, M | 2 |
| Laganà, AS | 1 |
| Bevilacqua, A | 2 |
| Pkhaladze, L | 1 |
| Benvenga, S | 2 |
| Stringaro, A | 1 |
| Barbaro, D | 1 |
| Appetecchia, M | 1 |
| Aragona, C | 1 |
| Bezerra Espinola, MS | 1 |
| Cantelmi, T | 1 |
| Cavalli, P | 3 |
| Chiu, TT | 2 |
| Copp, AJ | 2 |
| D'Anna, R | 14 |
| Dewailly, D | 1 |
| Di Lorenzo, C | 1 |
| Diamanti-Kandarakis, E | 1 |
| Hernández Marín, I | 1 |
| Hod, M | 2 |
| Kamenov, Z | 2 |
| Kandaraki, E | 2 |
| Monastra, G | 1 |
| Montanino Oliva, M | 1 |
| Nestler, JE | 1 |
| Nordio, M | 1 |
| Ozay, AC | 1 |
| Papalou, O | 1 |
| Porcaro, G | 1 |
| Prapas, N | 1 |
| Roseff, S | 1 |
| Vazquez-Levin, M | 1 |
| Vucenik, I | 1 |
| Wdowiak, A | 1 |
| Ibrahim, I | 1 |
| Abdullahi, H | 1 |
| Fagier, Y | 1 |
| Ortashi, O | 1 |
| Terrangera, A | 1 |
| Okunoye, G | 1 |
| DiNicolantonio, JJ | 1 |
| H O'Keefe, J | 1 |
| Amaefule, CE | 1 |
| Drymoussi, Z | 1 |
| Gonzalez Carreras, FJ | 1 |
| Pardo Llorente, MDC | 1 |
| Lanz, D | 1 |
| Dodds, J | 1 |
| Sweeney, L | 1 |
| Pizzo, E | 1 |
| Thomas, A | 1 |
| Heighway, J | 1 |
| Daru, J | 1 |
| Sobhy, S | 1 |
| Poston, L | 1 |
| Khalil, A | 1 |
| Myers, J | 1 |
| Harden, A | 1 |
| Hitman, G | 1 |
| Khan, KS | 2 |
| Zamora, J | 1 |
| Pérez, T | 1 |
| Huda, MSB | 1 |
| Thangaratinam, S | 2 |
| Vitacolonna, E | 4 |
| Masulli, M | 1 |
| Palmisano, L | 1 |
| Stuppia, L | 1 |
| Franzago, M | 2 |
| Li, L | 1 |
| Fang, J | 1 |
| Tang, Q | 1 |
| Zhong, Y | 1 |
| Xu, C | 1 |
| Li, W | 1 |
| Wang, H | 1 |
| Hou, Y | 1 |
| Liu, Q | 1 |
| Liu, Z | 2 |
| Esmaeilzadeh, S | 2 |
| Ghadimi, R | 1 |
| Mashayekh-Amiri, S | 2 |
| Delavar, MA | 2 |
| Basirat, Z | 1 |
| Guarnotta, V | 1 |
| Cuva, G | 1 |
| Imbergamo, MP | 1 |
| Giordano, C | 1 |
| Wei, J | 1 |
| Yan, J | 1 |
| Yang, H | 1 |
| Cracknell-Hazra, VKB | 1 |
| Pillai, RA | 2 |
| Selvam, P | 2 |
| Patmanathan, SN | 1 |
| Cazenave-Gassiot, A | 1 |
| Bendt, AK | 1 |
| Lewis, RM | 3 |
| Wenk, MR | 1 |
| Motuhifonua, SK | 1 |
| Lin, L | 1 |
| Alsweiler, J | 3 |
| Crawford, TJ | 2 |
| Crowther, CA | 3 |
| Greff, D | 1 |
| Váncsa, S | 1 |
| Váradi, A | 1 |
| Szinte, J | 1 |
| Park, S | 1 |
| Hegyi, P | 1 |
| Nyirády, P | 1 |
| Ács, N | 1 |
| Horváth, EM | 1 |
| Várbíró, S | 1 |
| Factor, PA | 1 |
| Corpuz, H | 1 |
| Guardo, FD | 2 |
| Currò, JM | 1 |
| Valenti, G | 1 |
| Rossetti, P | 1 |
| Di Gregorio, LM | 1 |
| Conway, F | 1 |
| Chiofalo, B | 1 |
| Garzon, S | 1 |
| Bruni, S | 1 |
| Rizzo, G | 1 |
| Santamaria, A | 6 |
| Alibrandi, A | 2 |
| Corrado, F | 11 |
| DI Benedetto, A | 10 |
| Plows, JF | 2 |
| Ramos Nieves, JM | 1 |
| Budin, F | 2 |
| Mace, K | 2 |
| Reynolds, CM | 1 |
| Vickers, MH | 2 |
| Silva-Zolezzi, I | 2 |
| Baker, PN | 2 |
| Stanley, JL | 2 |
| Sobota-Grzeszyk, A | 1 |
| Kuźmicki, M | 1 |
| Szamatowicz, J | 1 |
| Kısa, B | 1 |
| Sert, UY | 1 |
| Celik, HK | 1 |
| Candar, T | 1 |
| Erol Koç, EM | 1 |
| Taşcı, Y | 1 |
| Çağlar, GS | 1 |
| Tint, MT | 1 |
| Chang, HF | 1 |
| Wong, G | 1 |
| Yuan, WL | 1 |
| Tull, D | 1 |
| Nijagal, B | 1 |
| Narayana, VK | 1 |
| Meikle, PJ | 1 |
| Chang, KTE | 1 |
| Chi, C | 1 |
| Yap, FKP | 1 |
| Tan, KH | 1 |
| Shek, LP | 1 |
| Chong, YS | 1 |
| Gluckman, PD | 1 |
| Lee, YS | 1 |
| Fortier, MV | 1 |
| Eriksson, JG | 1 |
| Karnani, N | 1 |
| Griffith, RJ | 1 |
| Moore, AE | 1 |
| Brown, S | 1 |
| Middleton, P | 1 |
| Shepherd, E | 1 |
| Asimakopoulos, G | 1 |
| Pergialiotis, V | 1 |
| Anastasiou, E | 1 |
| Antsaklis, P | 1 |
| Theodora, M | 1 |
| Vogiatzi, E | 1 |
| Kallergi, A | 1 |
| Sindos, M | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Bakouei, F | 1 |
| Faramarzi, M | 1 |
| Greene, NDE | 1 |
| Islam, MO | 1 |
| Vitale, SG | 1 |
| Caruso, S | 1 |
| Giunta, L | 3 |
| Cianci, A | 1 |
| Kulshrestha, V | 1 |
| Balani, S | 1 |
| Kachhawa, G | 1 |
| Vanamail, P | 1 |
| Kumari, R | 1 |
| Sharma, JB | 1 |
| Bhatla, N | 1 |
| Chan, KY | 1 |
| Wong, MMH | 1 |
| Pang, SSH | 1 |
| Lo, KKH | 1 |
| Loddo, S | 1 |
| Gullo, G | 1 |
| Wang, L | 1 |
| Cheng, H | 1 |
| Wang, X | 1 |
| Zheng, L | 2 |
| Baldassarre, MPA | 2 |
| Di Tomo, P | 1 |
| Centorame, G | 1 |
| Pandolfi, A | 1 |
| Di Pietro, N | 1 |
| Consoli, A | 2 |
| Formoso, G | 2 |
| Farren, M | 2 |
| Daly, N | 1 |
| McKeating, A | 1 |
| Kinsley, B | 1 |
| Turner, MJ | 2 |
| Daly, S | 2 |
| Costabile, L | 1 |
| Dell'Edera, D | 1 |
| Sarlo, F | 1 |
| Allegretti, A | 1 |
| Epifania, AA | 1 |
| Simone, F | 1 |
| Lupo, MG | 1 |
| Benedetto, M | 1 |
| D'Apice, MR | 1 |
| Capalbo, A | 1 |
| Özturan, A | 1 |
| Arslan, S | 1 |
| Kocaadam, B | 1 |
| Elibol, E | 1 |
| İmamoğlu, İ | 1 |
| Karadağ, MG | 1 |
| Pintaudi, B | 7 |
| Di Vieste, G | 4 |
| Gateva, A | 1 |
| Guo, X | 1 |
| Guo, S | 1 |
| Miao, Z | 1 |
| Li, Z | 2 |
| Zhang, H | 2 |
| Lv, Y | 1 |
| Sun, L | 1 |
| Guo, W | 1 |
| Fraticelli, F | 1 |
| Celentano, C | 3 |
| Zecca, IA | 1 |
| Liberati, M | 3 |
| Di Nicola, M | 1 |
| Lucisano, G | 1 |
| Vitagliano, A | 1 |
| Saccone, G | 1 |
| Cosmi, E | 1 |
| Visentin, S | 1 |
| Dessole, F | 1 |
| Ambrosini, G | 1 |
| Berghella, V | 1 |
| Ginestra, F | 1 |
| Carlucci, MA | 1 |
| Bucci, I | 1 |
| Reyes-Muñoz, E | 1 |
| Ciebiera, M | 1 |
| Kahramanoglu, I | 1 |
| Sathyapalan, T | 1 |
| Lin, LT | 1 |
| Shah, M | 1 |
| Karaman, E | 1 |
| Fan, S | 1 |
| Zito, G | 1 |
| Noventa, M | 1 |
| Coustan, DR | 1 |
| Croze, ML | 1 |
| Costantino, D | 1 |
| Guaraldi, C | 1 |
| Rogozińska, E | 1 |
| Chamillard, M | 1 |
| Hitman, GA | 1 |
| Simmons, D | 1 |
| Scilipoti, A | 2 |
| Interdonato, ML | 3 |
| Petrella, E | 2 |
| Neri, I | 2 |
| Murphy, A | 1 |
| Shamshirsaz, A | 1 |
| Markovic, D | 1 |
| Ostlund, R | 1 |
| Koos, B | 1 |
| Baviera, G | 1 |
| Carlomagno, G | 2 |
| Lanzone, A | 1 |
| Soulage, C | 1 |
| Di Renzo, GC | 1 |
| Kamenov, ZA | 1 |
| Gerli, S | 1 |
| Oliva, MM | 1 |
| Devroey, P | 1 |
| Zheng, X | 1 |
| Zhang, Y | 1 |
| Lin, Y | 1 |
| Song, J | 1 |
| Lin, S | 1 |
| Brown, J | 1 |
| Matarrelli, B | 2 |
| Mattei, PA | 2 |
| Pavone, G | 2 |
| Lubin, V | 1 |
| Shojai, R | 1 |
| Darmon, P | 1 |
| Cosson, E | 1 |
| Werner, EF | 1 |
| Froehlich, RJ | 1 |
| Andersson, RA | 1 |
| Mills, VJ | 1 |
| Davidge, ST | 1 |
| Giordano, D | 2 |
| Di Benedetto, V | 1 |
| Rizzo, P | 1 |
| Raffone, E | 1 |
| D'Angelo, M | 1 |
| Caruso, C | 1 |
| Cannata, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Myoinositol on Serum Asprosin Levels in Pregnant Women[NCT05943158] | 40 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
| The Effect Birth Outcome and Diabetes Management of Planned Behavior Theory Based Education Model in Women With Gestational Diabetes[NCT04874922] | 66 participants (Actual) | Interventional | 2021-05-15 | Completed | |||
| Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes, Diet Treated: a Prospective, Randomized, Placebo-controlled Study[NCT03763669] | 120 participants (Actual) | Interventional | 2018-11-14 | Completed | |||
| Different Effects of Inositol Stereoisomers on Insulin Sensitivity in Women With Gestational Diabetes[NCT02097069] | 80 participants (Anticipated) | Interventional | 2014-04-30 | Not yet recruiting | |||
| Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial[NCT04273256] | Phase 2/Phase 3 | 226 participants (Anticipated) | Interventional | 2020-02-11 | Recruiting | ||
| Effects of a Supplementation With Zinc and Myo-inositol in Paediatric Obesity[NCT03283813] | Phase 4 | 60 participants (Anticipated) | Interventional | 2018-02-05 | Recruiting | ||
| Reduction of Insulin Therapy Under Myo-inositol for the Treatment of Gestational Diabetes Mellitus: a Randomized Multicenter and Prospective Trial. MYO-GDM Study[NCT03875755] | 1,080 participants (Anticipated) | Interventional | 2020-03-04 | Recruiting | |||
| Myo-inositol May Prevent Gestational Diabetes in Obese Women[NCT01047982] | 220 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| Improved Maternal and Fetal Outcomes Associated With Inositol Dietary Supplementation in Women With Early Gestational Diabetes Mellitus[NCT01342874] | 30 participants (Actual) | Observational | 2010-08-31 | Completed | |||
| [NCT01511835] | Phase 4 | 0 participants | Interventional | Recruiting | |||
| [NCT01511822] | Phase 4 | 0 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for inositol and Diabetes, Gestational
| Article | Year |
|---|---|
Topics: Diabetes, Gestational; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Inositol | 2023 |
Inositols: From Established Knowledge to Novel Approaches.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Molecular Structure; Polycystic Ovary Syndrome; Pre | 2021 |
Inositols, Probiotics, and Gestational Diabetes: Clinical and Epigenetic Aspects.
Topics: Diabetes, Gestational; Dietary Supplements; Epigenesis, Genetic; Female; Humans; Inositol; Pregnancy | 2022 |
Myo-inositol supplementation for the prevention of gestational diabetes: A meta-analysis of randomized controlled trials.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Infant, Newborn; Inositol; Pregnancy; Ra | 2022 |
Effectiveness of five interventions used for prevention of gestational diabetes: A network meta-analysis.
Topics: Diabetes, Gestational; Exercise; Female; Humans; Inositol; Network Meta-Analysis; Pregnancy; Probiot | 2022 |
The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Glucose; Humans; Incidence; Infant, Newborn; Ino | 2022 |
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Humans; Infant, Newborn; Inositol | 2022 |
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypert | 2023 |
Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Diabetes, Gestational; Female; Humans; Hypertension, Pregnancy-Induced; Hypoglycemia; Infant, Newbor | 2023 |
The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypertension, Pregnancy-Induced; Infant, | 2023 |
Non-pharmacological management of gestational diabetes: The role of myo-inositol.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Fetal Development; Humans; Inositol; Pregnancy | 2019 |
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review.
Topics: Adult; Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Risk Factors | 2019 |
Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
Topics: Animals; Biomarkers; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypo | 2019 |
Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.
Topics: Diabetes, Gestational; Diet, Diabetic; Dietary Supplements; Exercise; Fatty Acids, Omega-3; Female; | 2020 |
An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs).
Topics: Animals; Diabetes, Gestational; Female; Humans; Infant, Newborn; Inositol; Insulin; Neural Tube Defe | 2020 |
A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Insulin; Placenta; Polycystic Ovary Syndrome; Pregn | 2022 |
Dietary supplementation for gestational diabetes prevention and management: a meta-analysis of randomized controlled trials.
Topics: Adult; Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Randomized C | 2021 |
Effect of inositol and its derivatives on diabetes: a systematic review.
Topics: Animals; Blood Glucose; Databases, Factual; Diabetes Mellitus, Type 2; Diabetes, Gestational; Fastin | 2019 |
The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Insulin Resistance; Polycystic Ovary Syndrome; Preg | 2018 |
Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Pregnancy; Randomized Controlled Trials as Topic; V | 2018 |
The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials.
Topics: Adult; Diabetes, Gestational; Female; Gestational Age; Humans; Inositol; Pregnancy; Premature Birth; | 2019 |
Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Infant, Newborn; Inositol; Insulin; Odd | 2019 |
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Humans; In | 2019 |
Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Pregnancy | 2019 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a meta-analysis of randomised studies.
Topics: Clinical Trials as Topic; Databases, Factual; Diabetes, Gestational; Female; Humans; Inositol; Nutri | 2015 |
Prevention of gestational diabetes mellitus: Where are we now?
Topics: Diabetes, Gestational; Diet; Dietary Supplements; Exercise Therapy; Female; Humans; Hypoglycemic Age | 2015 |
Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Vitamin B Complex | 2015 |
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.
Topics: Diabetes, Gestational; Female; Humans; Incidence; Inositol; Isomerism; Pregnancy; Prenatal Care; Ran | 2015 |
Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus.
Topics: Animals; Diabetes, Gestational; Dietary Supplements; Female; Humans; Incidence; Inositol; Insulin Re | 2016 |
15 trials available for inositol and Diabetes, Gestational
| Article | Year |
|---|---|
Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Humans; Incidence; In | 2022 |
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.
Topics: Diabetes, Gestational; Double-Blind Method; Female; Humans; Inositol; Insulin Resistance; Male; Pilo | 2022 |
The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Folic Acid; Humans; Inositol; Insulin Resistance | 2023 |
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Glucose Tolerance Test; Glycated Hemoglobin; Gre | 2020 |
The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Folic Acid; Humans; Infant; Inositol; Pregnancy; | 2022 |
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Topics: Diabetes, Gestational; Dietary Supplements; Electric Impedance; Female; Folic Acid; Humans; Infant, | 2021 |
Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial.
Topics: Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; India; Inositol; Insulin; Metformin; Pil | 2021 |
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study.
Topics: Adult; Birth Weight; Case-Control Studies; Diabetes, Gestational; Dietary Supplements; Female; Folic | 2021 |
The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.
Topics: Administration, Oral; Adolescent; Adult; Diabetes, Gestational; Dietary Supplements; Female; Glucose | 2017 |
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
Topics: Adolescent; Adult; Diabetes, Gestational; Dose-Response Relationship, Drug; Female; Humans; Inositol | 2018 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes, Gestational; Dietary Supplements; Female; Humans; I | 2016 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
Topics: Adult; Case-Control Studies; Diabetes, Gestational; Dietary Supplements; Double-Blind Method; Female | 2013 |
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Pregnancy; Prospective S | 2013 |
24 other studies available for inositol and Diabetes, Gestational
| Article | Year |
|---|---|
Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Insulin; Insulin Resistance; Polycystic Ovary Syndr | 2022 |
Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes.
Topics: Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glycemic Control; Humans; Infant, | 2022 |
Myo-Inositol Moderates Glucose-Induced Effects on Human Placental
Topics: Arachidonic Acid; Diabetes, Gestational; Ethanolamines; Female; Glucose; Humans; Inositol; Phospholi | 2022 |
The effects of myo-inositol and probiotic supplementation in a high-fat-fed preclinical model of glucose intolerance in pregnancy.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes, Gestational; Diet, High-Fat; Dietary Supplements; | 2020 |
Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus.
Topics: Blood Glucose; Diabetes, Gestational; Female; Humans; Inositol; Inositol Oxygenase; Insulin; Insulin | 2022 |
High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: the GUSTO cohort.
Topics: Adiposity; Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Humans; Infant, Newbor | 2021 |
Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression.
Topics: Adult; Blood Glucose; Case-Control Studies; Cells, Cultured; Diabetes, Gestational; Down-Regulation; | 2021 |
Effectiveness and acceptability of myoinositol in prevention of gestational diabetes mellitus: A protocol for systematic review and meta-analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Meta-Analysis as Topic; Pregna | 2021 |
Myoinositol Reduces Inflammation and Oxidative Stress in Human Endothelial Cells Exposed In Vivo to Chronic Hyperglycemia.
Topics: Adult; Antioxidants; Cell Adhesion; Cell Adhesion Molecules; Diabetes, Gestational; Female; Human Um | 2021 |
Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Inositol; Pregnancy | 2017 |
Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results.
Topics: Adult; Diabetes, Gestational; Dietary Supplements; Female; Glucose Tolerance Test; Glycated Hemoglob | 2017 |
Comment on Farren et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care 2017;40:759-763.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Nutrition Therapy; Pregn | 2017 |
Response to Comment on Farren et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care 2017;40:759-763.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Nutrition Therapy; Pregn | 2017 |
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Fetal Growth R | 2018 |
Effects of myo-inositol on glucose variability in women with gestational diabetes.
Topics: Adult; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes, Gestational; Dietary Supplements; | 2018 |
Can a dietary supplement prevent gestational diabetes mellitus?
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Pregnancy | 2013 |
[Role of D-chiro-inositol in glucidic metabolism alterations during pregnancy].
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Hunger; Hypoglycemia; Hypoglycemic Agen | 2014 |
Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus.
Topics: Adult; Biomarkers; Case-Control Studies; Diabetes, Gestational; Female; Gas Chromatography-Mass Spec | 2016 |
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension.
Topics: Adult; Amniotic Fluid; Case-Control Studies; Diabetes, Gestational; Female; Humans; Hypertension, Pr | 2016 |
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.
Topics: Congenital Abnormalities; Diabetes, Gestational; Female; Humans; Inositol; Insulin Resistance; Metab | 2015 |
A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin.
Topics: Adult; Blood Glucose Self-Monitoring; Combined Modality Therapy; Diabetes, Gestational; Diet; Female | 2016 |
The Potential Role for Myoinositol in the Prevention of Gestational Diabetes Mellitus.
Topics: Animals; Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Randomized | 2016 |
The Effects of Myo-Inositol and B and D Vitamin Supplementation in the db/+ Mouse Model of Gestational Diabetes Mellitus.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Experimental; Diabetes, Gestational; Dietary Supplements | 2017 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |